AbbVie
ABBV
2,411 hedge funds and large institutions have $121B invested in AbbVie in 2020 Q2 according to their latest regulatory filings, with 265 funds opening new positions, 1,284 increasing their positions, 673 reducing their positions, and 55 closing their positions.
382% more first-time investments, than exits
New positions opened: 265 | Existing positions closed: 55
91% more repeat investments, than reductions
Existing positions increased: 1,284 | Existing positions reduced: 673
46% more capital invested
Capital invested by funds: $82.7B → $121B (+$38.2B)
31% more funds holding in top 10
Funds holding in top 10: 150 → 197 (+47)
8% more funds holding
Funds holding: 2,225 → 2,411 (+186)
3.83% less ownership
Funds ownership: 73.75% → 69.92% (-3.8%)
13% less call options, than puts
Call options by funds: $1.85B | Put options by funds: $2.12B
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$1.93B |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.92B |
| 3 |
State Street
Boston,
Massachusetts
|
+$1.01B |
| 4 |
N
Nuveen
Charlotte,
North Carolina
|
+$613M |
| 5 |
JP Morgan Chase
New York
|
+$547M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$504M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$320M |
| 3 |
Capital Research Global Investors
Los Angeles,
California
|
-$275M |
| 4 |
OAG
Orbis Allan Gray
Hamilton,
Bermuda
|
-$264M |
| 5 |
Citigroup
New York
|
-$215M |
ABBV Hedge Fund Activity: Q2 2020 in Review
2,411 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in AbbVie (ABBV) for Q2 2020, worth a combined $121B — up 46% from $82.7B a quarter earlier.
Buyers outnumbered sellers: 265 funds opened new ABBV positions and 55 closed out — a net gain of 210 holders — while 1,284 added to existing stakes and 673 trimmed.
The largest buyer was BlackRock, adding an estimated $1.93B. The largest seller was Arrowstreet Capital, cutting an estimated $504M.
- 2,411 institutional investors held AbbVie (ABBV) as of Q2 2020, up from 2,225 in Q1 2020.
- Funds reported $121B of AbbVie stock for Q2 2020, up 46% quarter-over-quarter.
- 265 funds opened new AbbVie positions in Q2 2020 and 55 closed out, a net change of +210 holders.
- The largest AbbVie buyer in Q2 2020 was BlackRock, an estimated $1.93B added.
- The largest AbbVie seller in Q2 2020 was Arrowstreet Capital, an estimated $504M sold.
Based on aggregated 13F filings for Q2 2020.